Disclosure s : Chabner reports professional relationships with BioMarin, Celgene, Eli Lilly, Epizyme, Gilead Sciences, Merrimack, Pharmacyclics, Sanofi, Seattle Genetics and Zeltia
Still, more large-scale research is needed
To view or add a comment, sign in Challenges in Cardiovascular Research While cardiovascular research has made significant progress, several challenges still hinder the field's full potential: Complexity of Cardiovascular Diseases: Cardiovascular diseases are multifactorial, involving genetic, environmental, and lifestyle factors
J.MoranL
Related Compounds Researchers investigating BPC-157 often also study TB-500, as the two peptides are frequently examined together in tissue-repair research, including combination formulations such as the BPC-157/TB-500 blend, Klow, and Glow available in the catalog